Aspirin vs Durvalumab

## Aspirin vs Durvalumab: Overview

This comparison examines the pharmacological differences between **Aspirin** and **Durvalumab**.

## Mechanism of Action

**Aspirin**: Irreversibly inhibits cyclooxygenase-1 and -2.

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

## Pharmacokinetics

**Half-life**: Aspirin — 2-3 hours; Durvalumab — 17 days.

## Chemical Properties

**Molecular Formula**: Aspirin — C9H8O4; Durvalumab — N/A.

**Molecular Weight**: Aspirin — 180.1580 g/mol; Durvalumab — N/A.

**Type**: Aspirin — Small molecule; Durvalumab — Antibody.